- 商品介绍
- 规格参数
- 包装参数
规格 |
|
Antibiotic Resistance Bacterial: | Ampicillin (AmpR), Blasticidin (BsdR) |
Cleavage: | No Cleavage Site |
Cloning Method: | Gateway® |
Gateway Enzyme: | LR Clonase® II Plus, LR Clonase® II |
Key Functions: | Viral Expression |
PCR Enzyme: | Proof-Reading Polymerase |
Product Line: | Gateway®, HiPerform™, T-REx™, ViraPower™ |
Protein Tag Position (to your gene): | C-terminal |
Replication Origin: | pUC Origin |
Selection Marker Eukaryotic: | BsdR |
Selection Marker Promoter: | PGK Promoter |
Special Elements: | WPRE, cPPT |
Constitutive or Inducible System: | Inducible |
Delivery Type: | Lentiviral |
Inducing Agent: | Doxycycline, Tetracycline |
Promoter: | CMV⁄TO |
Selection Agent (Eukaryotic): | Blasticidin |
Vector: | pLenti |
Protein Tag: | V5 Epitope Tag |
储存 |
|
Contents The ViraPower™ HiPerform™ T-REx™ Gateway® Vector Kit includes the following components: • 6 ug of pLenti6.3⁄TO⁄V5-DEST™ vector (40 µL of vector at 150 ng⁄µL in TE Buffer, pH 8.0) • 20 ug of pLenti3.3⁄TR vector (40 µL of vector at 0.5 µg⁄µL in TE Buffer, pH 8.0) • 10 ug of pLenti6.3⁄TO⁄V5-GW⁄lacZ plasmid (20 µL of plasmid at 0.5 µg⁄µL in TE Buffer, pH 8.0) • 1 ml of Tetracycline (10 mg⁄mL in water) • One Shot™ Stbl3™ Chemically Competent E. coli (Cat # C737303): 21 X 50 µL of Stbl3™ Cells, 6 mL of S.O.C. Medium and 50 µL of pUC19 control DNA (10 pg⁄µL). • pENTR™ Gus positive control plasmid. Storage • Vectors: -20°C • Tetracycline: -20°C (protected from light) • One Shot™ Stbl3™ Chemically Competent E. coli: -80°C • pENTR™ Gus positive Control: -20°C |
描述 |
The ViraPower™ HiPerform™ T-REx™ Gateway® Vector Kit contains the Gateway®-adapted ViraPower™ HiPerform™ tetracycline-regulated lentiviral expression vector, pLenti6.3⁄TO⁄V5-DEST™ for easy recombination-based cloning and lentiviral-based, regulated, high-level expression of a target gene in dividing and non-dividing mammalian cells. The pLenti6.3⁄ TO⁄ V5-DEST™ vector is equipped with two key genetic elements, making it a HiPerform™ vector: the Woodchuck Posttranscriptional Regulatory Element (WPRE) and the central Polypurine Tract (cPPT) sequence from the HIV-1 integrase gene to produce at least 4-fold increase in protein expression compared to vectors lacking these elements.
Advantages
• Generates replication-incompetent lentivirus for transducing dividing and non-dividing mammalian cells
• Easy recombination-based cloning using Gateway® technology
• Stable, long-term, tetracycline-regulated expression
• Enhanced protein expression, up to 4-fold or greater, compared to traditional lentiviral expression systems
Key Features
• WPRE from the woodchuck hepatitis virus, increases transgene expression and cPPT from the HIV-1 integrase gene, increases the copy number of lentivirus integrating into the host genome, thus increasing viral titer. WPRE and cPPT together produce at least a four-fold increase in protein expression in most cell types, compared to other vectors that do not contain these elements.
• Hybrid promoter consisting of the human cytomegalovirus (CMV) promoter and two tetracycline operator 2 (TetO2) sites for high-level, regulated expression of the target gene
• Blasticidin selection marker for stable selection under control of SV40 promoter
Kit includes
• pLenti6.3⁄TO⁄V5-DEST™ vector
• pLenti3.3⁄TR vector
• pLenti6.3⁄TO⁄V5-GW⁄lacZ plasmid
• Tetracycline
• One Shot® Stbl3™ Chemically Competent E. coli (Cat # C737303)
• pENTRTM Gus positive control plasmid.
For research use only. Not intended for any therapeutic or diagnostic use.
长度(mm) | |
宽度(mm) | |
高度(mm) | |
重量(kg) |